von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report by Claudia Djambas Khayat, Anna Pavlova, Sylvia Werner, Sigurd Knaub, Robert F. Sidonio

Get full text

Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease – WIL-31 study post... by Robert F. Sidonio, Jr., Leonid Dubey, Kateryna V. Vilchevska, Adlette Inati, Claudia Djambas Khayat

Get full text

Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women wi... by Csongor Kiss, Zoltan Boda, Claudia Djambas Khayat, Ana Boban, Leonid Dubey, Robert F. Sidonio Jr

Get full text

Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice by Robert F. Sidonio, Jr., Guy Young, Carmen Escuriola Ettingshausen, Johnny Mahlangu, Margareth C. Ozelo, Alok Srivastava, Jerzy Windyga, Hye–Youn Lee, Aurelia Lelli, Steven W. Pipe

Get full text

Treatment of severe bleeds with eptacog beta in hemophilia A or B with inhibitors: a post hoc analysis of the PERSEPT 1 and 2 trials by Guy Young, Johnny Mahlangu, Lisa N. Boggio, Manuel Carcao, Yesim Dargaud, Miguel Escobar, Adam Giermasz, Cédric Hermans, Philip Kuriakose, Wolfgang Miesbach, Danielle Nance, Amina Rafique, Robert F. Sidonio, Jr., Kateryna V. Vilchevska, Michael Wang, Steven W. Pipe

Get full text